Latest Posts › Food and Drug Administration (FDA)

Share:

Part 5: Hemp & CBD

With the cannabis space continuing its significant pace of growth, the industry has witnessed new players enter the arena: hemp and cannabidiol (“CBD”). The demand for hemp and CBD has skyrocketed in recreational, industrial,...more

State of the Cannabis Industry Conference: Capital Markets, Investments, M&A, Regulatory and Other Timely Issues

In both the Commonwealth and New England — and, indeed, the country — these are exciting times for the cannabis industry. As a consensus on the topic of legalization continues to build, technology and banking, specifically,...more

The Path to Greenlighting CBD

Last week, the industry was energized by the Drug Enforcement Administration’s order placing certain drugs containing cannabidiol, or CBD, in Schedule V of the Controlled Substances Act. This marks the first time in history...more

3 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide